ASTELLAS PHARMA INC. Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 1.506 JPY | +3,51% |
|
+1,72% | -10,68% |
| 25/04 | Transcript : Astellas Pharma Inc., 2024 Earnings Call, Apr 25, 2024 | |
| 25/04 | Astellas Pharma Inc. kondigt pensionering van bestuur en comité aan | CI |
Totale waarde
| Fiscaal tijdperk: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 3.186.231 | 3.105.395 | 3.161.421 | 3.519.738 | 3.381.409 | 2.700.238 | - | - |
| Bedrijfswaarde 1 | 2.875.157 | 2.777.545 | 2.829.733 | 3.203.752 | 3.004.569 | 2.946.773 | 3.212.253 | 3.121.296 |
| K/w-verhouding | 14,4 x | 16 x | 26,2 x | 28,5 x | 34,7 x | 173 x | 23,5 x | 15,6 x |
| Dividendrendement | 2,29% | 2,39% | 2,47% | 2,62% | 3,19% | 4,69% | 4,93% | 5,27% |
| Marktkapitalisatie/omzet | 2,44 x | 2,39 x | 2,53 x | 2,72 x | 2,23 x | 1,84 x | 1,62 x | 1,54 x |
| Bedrijfswaarde/omzet | 2,2 x | 2,14 x | 2,26 x | 2,47 x | 1,98 x | 1,84 x | 1,93 x | 1,78 x |
| Bedrijfswaarde/EBITDA | 9,35 x | 8,95 x | 13,6 x | 13,6 x | 12,6 x | 16,1 x | 11 x | 7,76 x |
| Bedrijfswaarde/FCF | 12,3 x | -16,6 x | 10,3 x | 14,1 x | 10,3 x | -5,46 x | 13 x | 11,3 x |
| FCF Yield | 8,12% | -6,04% | 9,73% | 7,08% | 9,7% | -18,3% | 7,71% | 8,83% |
| Price to Book | 2,49 x | 2,41 x | 2,28 x | 2,39 x | 2,24 x | 1,85 x | 1,83 x | 1,76 x |
| Aantal aandelen (in duizenden) | 1.921.152 | 1.858.405 | 1.857.474 | 1.841.831 | 1.795.756 | 1.792.986 | - | - |
| Referentieprijs 2 | 1.658 | 1.671 | 1.702 | 1.911 | 1.883 | 1.506 | 1.506 | 1.506 |
| Datum van publicatie | 25-04-19 | 14-05-20 | 27-04-21 | 27-04-22 | 27-04-23 | 25-04-24 | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 1.306.348 | 1.300.843 | 1.249.528 | 1.296.163 | 1.518.619 | 1.603.672 | 1.664.834 | 1.758.430 |
| EBITDA 1 | 307.370 | 310.387 | 208.703 | 235.370 | 238.767 | 183.358 | 290.770 | 402.117 |
| Bedrijfsresultaat (EBIT) 1 | 243.912 | 243.991 | 136.051 | 155.686 | 133.029 | 25.518 | 150.368 | 231.489 |
| Operationele Marge | 18,67% | 18,76% | 10,89% | 12,01% | 8,76% | 1,59% | 9,03% | 13,16% |
| Resultaat voor belastingen (EBT) 1 | 248.967 | 245.350 | 145.324 | 156.886 | 132.361 | 24.969 | 151.955 | 226.419 |
| Nettowinst (verlies) 1 | 222.265 | 195.411 | 120.589 | 124.086 | 98.714 | 17.045 | 115.512 | 173.587 |
| Nettomarge | 17,01% | 15,02% | 9,65% | 9,57% | 6,5% | 1,06% | 6,94% | 9,87% |
| WPA 2 | 115,0 | 104,2 | 64,93 | 67,08 | 54,24 | 9,510 | 64,11 | 96,59 |
| Free Cash Flow 1 | 233.440 | -167.795 | 275.459 | 226.705 | 291.326 | -586.348 | 247.573 | 275.506 |
| FCF-marge | 17,87% | -12,9% | 22,05% | 17,49% | 19,18% | -37,3% | 14,87% | 15,67% |
| Kasstroomconversie (ebitda) | 75,95% | - | 131,99% | 96,32% | 122,01% | - | 85,14% | 68,51% |
| Kasstroomconversie (nettowinst) | 105,03% | - | 228,43% | 182,7% | 295,12% | - | 214,33% | 158,71% |
| Dividend per aandeel 2 | 38,00 | 40,00 | 42,00 | 50,00 | 60,00 | 70,62 | 74,27 | 79,36 |
| Datum van publicatie | 25-04-19 | 14-05-20 | 27-04-21 | 27-04-22 | 27-04-23 | 25-04-24 | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: March | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2025 S2 | 2026 S1 | 2026 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 650.470 | - | 615.480 | - | 325.523 | 651.666 | 340.627 | 303.870 | - | 381.791 | 380.394 | 762.185 | 402.180 | 354.254 | 374.990 | 392.148 | 767.138 | 421.932 | 414.602 | - | 408.629 | 428.866 | 800.647 | 457.556 | 402.032 | - | - | - |
| EBITDA 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 70.087 | 42 | - | - | - | - | - | - | - | - | - |
| Bedrijfsresultaat (EBIT) 1 | 162.196 | - | 86.872 | - | 54.079 | 90.169 | 79.202 | -13.685 | - | 33.147 | 86.744 | 119.891 | 61.388 | -48.250 | 45.794 | 5.222 | 51.016 | 23.103 | -48.601 | - | 32.152 | 45.700 | 83.888 | 49.695 | -64.050 | - | - | - |
| Operationele Marge | 24,94% | - | 14,11% | - | 16,61% | 13,84% | 23,25% | -4,5% | - | 8,68% | 22,8% | 15,73% | 15,26% | -13,62% | 12,21% | 1,33% | 6,65% | 5,48% | -11,72% | - | 7,87% | 10,66% | 10,48% | 10,86% | -15,93% | - | - | - |
| Resultaat voor belastingen (EBT) 1 | 161.584 | - | 89.091 | - | 53.255 | 89.085 | 78.317 | -10.516 | - | 31.679 | 88.801 | 120.480 | 59.758 | -47.877 | 46.850 | 5.328 | 52.178 | 21.452 | -48.661 | - | 31.628 | 33.394 | 80.888 | 45.792 | -41.144 | - | - | - |
| Nettowinst (verlies) 1 | 128.527 | - | 72.838 | - | 40.922 | 71.609 | 60.886 | -8.409 | - | 24.812 | 71.622 | 96.434 | 48.405 | -46.125 | 33.129 | -1.459 | 31.670 | 18.653 | -33.278 | - | 23.670 | 25.467 | 59.857 | 34.924 | -31.769 | - | - | - |
| Nettomarge | 19,76% | - | 11,83% | - | 12,57% | 10,99% | 17,87% | -2,77% | - | 6,5% | 18,83% | 12,65% | 12,04% | -13,02% | 8,83% | -0,37% | 4,13% | 4,42% | -8,03% | - | 5,79% | 5,94% | 7,48% | 7,63% | -7,9% | - | - | - |
| WPA 2 | 68,16 | - | 39,21 | - | 22,09 | 38,65 | 32,86 | -4,430 | - | 13,59 | 39,28 | 52,87 | 26,56 | -25,19 | 18,46 | -0,8000 | 17,66 | 10,40 | -18,55 | - | 12,15 | 18,05 | 33,40 | 20,20 | -29,06 | - | - | - |
| Dividend per aandeel 2 | 20,00 | 20,00 | 21,00 | 21,00 | - | 25,00 | - | - | 25,00 | - | - | 30,00 | - | - | - | 35,00 | 35,00 | - | 35,00 | 35,00 | - | - | 37,00 | - | - | 37,00 | 39,00 | 39,00 |
| Datum van publicatie | 31-10-19 | 14-05-20 | 30-10-20 | 27-04-21 | 29-10-21 | 29-10-21 | 02-02-22 | 27-04-22 | 27-04-22 | 01-08-22 | 31-10-22 | 31-10-22 | 06-02-23 | 27-04-23 | 01-08-23 | 01-11-23 | 01-11-23 | 05-02-24 | 25-04-24 | - | - | - | - | - | - | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Balans
| Fiscaal tijdperk: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | - | - | - | - | - | 503.449 | 512.015 | 421.059 |
| Nettokaspositie 1 | 311.074 | 327.850 | 331.688 | 315.986 | 376.840 | - | - | - |
| Hefboom (schuld/ebitda) | - | - | - | - | - | 1,9 x | 1,761 x | 1,047 x |
| Free Cash Flow 1 | 233.440 | -167.795 | 275.459 | 226.705 | 291.326 | -586.348 | 247.573 | 275.506 |
| ROE (netto-inkomsten/eigen vermogen) | 17,6% | 15,3% | 9% | 8,7% | 6,7% | 1,1% | 7,5% | 11,5% |
| ROA (netto-inkomsten/totale activa) | 13,3% | 11,6% | 6,33% | 6,81% | 5,53% | 4,43% | 4,48% | 7,23% |
| Totale activa 1 | 1.676.516 | 1.678.858 | 1.905.121 | 1.821.523 | 1.785.770 | 302.888 | 2.576.384 | 2.399.595 |
| Nettoactief per aandeel 2 | 667,0 | 694,0 | 748,0 | 799,0 | 839,0 | 890,0 | 821,0 | 858,0 |
| Cashflow per aandeel 2 | 148,0 | 140,0 | 104,0 | 110,0 | 112,0 | 97,50 | 179,0 | 195,0 |
| Capex 1 | 25.190 | 41.267 | 31.384 | 30.739 | 36.441 | 50.975 | 61.860 | 58.060 |
| Capex/omzet | 1,93% | 3,17% | 2,51% | 2,37% | 2,4% | 3,24% | 3,72% | 3,3% |
| Datum van publicatie | 25-04-19 | 14-05-20 | 27-04-21 | 27-04-22 | 27-04-23 | 25-04-24 | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Historische marktkapitalisatie/EBITDA
Trading rating
Beleggingsrating
ESG Refinitiv
A
Verkoop
Koop
Gemiddeld advies
Accumuleren
Aantal analisten
16
Laatste slotkoers
1.506
JPY
Gemiddelde koersdoel
2.025
JPY
Spread / Gemiddelde doel
+34,46%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| -10,68% | 17,15 mld. | |
| +25,83% | 661 mld. | |
| +27,00% | 566 mld. | |
| -6,76% | 352 mld. | |
| +20,34% | 332 mld. | |
| +3,00% | 283 mld. | |
| +13,09% | 231 mld. | |
| +5,46% | 200 mld. | |
| -9,61% | 195 mld. | |
| -6,26% | 145 mld. |
- Beurs
- Aandelen
- Koers 4503
- Financiën Astellas Pharma Inc.
